Peptides and SARMS

Raloxifene

Manufacturer: Dragon Pharma
Substance: Raloxifene Hydrochloride
Pack: 100 tabs (16 mg/tab)

$171.00

Shipping From:

U.S. Domestic

Raloxifene 60mg by Dragon Pharma - PCT, Estrogen Control & Gynecomastia Prevention for Athletes

Raloxifene 60mg by Dragon Pharma is a selective estrogen receptor modulator (SERM) widely used in the athletic community for precise estrogen control, effective post-cycle therapy (PCT), and gynecomastia prevention. Unlike aromatase inhibitors that blunt estrogen production, Raloxifene selectively blocks estrogen receptors in breast tissue while preserving beneficial estrogen activity elsewhere - a valuable tool for athletes who want to balance recovery, libido, and long-term health after anabolic use.

Dragon Pharma produces Raloxifene with pharmaceutical-grade purity and consistent dosing, which matters for PCT protocols where small differences can change outcomes. For lifters, competitors, and enhanced athletes, Raloxifene provides a predictable, well-tolerated option to manage estrogenic side effects while supporting a controlled hormonal rebound after a cycle.

Why Use Raloxifene for PCT and Estrogen Control?

Raloxifene acts as an estrogen receptor antagonist in breast tissue - this makes it particularly effective at preventing or reversing gynecomastia (tender or enlarged breast tissue) without causing total estrogen depletion.
During PCT, the goal is to restore natural testosterone production while preventing estrogen from causing unwanted effects. Raloxifene helps by blocking estrogen's action where it matters most (breast tissue) and allowing the hypothalamic-pituitary-gonadal (HPG) axis to recover more cleanly than with blunt estrogen suppression.

Key Athlete Benefits

• Targets gynecomastia prevention and reversal without full estrogen shutdown
• Supports hormonal balance during HPTA recovery after anabolic cycles
• Generally better tolerability vs high-dose aromatase inhibitors for long PCT runs
• Preserves bone-protective estrogenic activity while controlling breast receptors
• Good alternative for users sensitive to AI-related joint pain or lipid changes

Typical Protocols & Dosage Recommendations

Simple PCT (begin 2–3 days after last long ester injection or 24–48h after short esters):
• Raloxifene 60mg once daily for 4–6 weeks

Gynecomastia treatment / prevention during cycle (if early signs appear):
• Raloxifene 60mg daily until tenderness subsides, then continue at 30–60mg for 2–4 weeks as needed

Advanced rebound protocol (combined):
• Raloxifene 60mg daily + Clomiphene 50mg daily for 4 weeks, then lower clomiphene to 25mg for 2 weeks while continuing raloxifene as needed

Always monitor symptoms and consult lab work (LH, FSH, total testosterone) when available. Adjust based on response and side-effect profile.

How Raloxifene Compares - Practical Table

Product	Primary Action	Strengths	Best For
Raloxifene 60mg	Estrogen receptor modulation (breast antagonist)	Gynecomastia control, PCT support, bone-sparing	PCT, gynecomastia prevention/reversal
Tamoxifen (Nolvadex)	Estrogen receptor modulator (breast antagonist)	Widely used PCT, proven for gynecomastia	Standard PCT & gyn treatment
Anastrozole (AI)	Aromatase inhibitor - lowers estrogen synthesis	Powerful estrogen suppression	High aromatizing cycles (but higher side effects)

Stacking Strategies & Practical Tips

Standard PCT stack: Raloxifene 60mg/day (4–6 weeks) + Clomiphene (Clomid) 50mg/day for first 2–4 weeks then taper.
When to prefer Raloxifene over Tamoxifen: Use raloxifene if you want targeted breast protection with potentially fewer estrogen-related side effects (some users tolerate raloxifene better).
When to add an AI: If blood tests show high systemic estrogen (estradiol) with problematic symptoms (water retention, high blood pressure), consider low-dose anastrozole under supervision - but avoid routine long-term AI use during PCT because it can hamper HPTA recovery.

Safety, Side Effects & Lab Monitoring

Common side effects are usually mild: hot flashes, slight fatigue, or transient mood changes.
Rare but important: raloxifene is associated with a small increased risk of venous thromboembolism - avoid in users with blood-clot history or strong risk factors. Encourage hydration, movement, and consult a doctor if you have risk factors.
Recommended labs during/after PCT: total testosterone, free testosterone, LH, FSH, estradiol, and lipid panel if running AIs or SERMs long-term.

For related protocols and stacks check:

Testosterone Cypionate
BPC-157 (Kalpa)

Frequently Asked Questions

1. Can Raloxifene reverse established gynecomastia?
Raloxifene is effective at reducing tenderness and early glandular enlargement; long-standing fibrotic gyno often requires surgical correction. Early treatment improves outcomes.

2. Is Raloxifene better than Tamoxifen for PCT?
Both work. Raloxifene offers strong breast receptor antagonism and may be better tolerated for some users; Tamoxifen is more widely used and extremely well-studied for PCT. Choice depends on individual response and clinician guidance.

3. Will Raloxifene block estrogen everywhere?
No. Raloxifene selectively blocks estrogen receptors in breast tissue while allowing beneficial estrogen activity in bone and other tissues - that's why it's bone-sparing compared to AIs.

4. How long should I run Raloxifene after a cycle?
Common protocols use 4–6 weeks; monitor labs and symptoms and extend only if clinically indicated.

5. Any critical safety warnings?
Avoid use if you have history of deep-vein thrombosis, pulmonary embolism, or active clotting disorders. Always consult a healthcare professional if you have cardiovascular risk factors.

No reviews found

Please log in to write Raloxifene review.

Related Offers

Domestic & International

Dragon Pharma, Europe

Cut Mix 150

Manufacturer: Dragon Pharma, Europe
Pharmaceutical name: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Pack: 10 ml vial (150 mg/ml)

$72.00